Michelle Schmiegelow

1.2k total citations
34 papers, 810 citations indexed

About

Michelle Schmiegelow is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michelle Schmiegelow has authored 34 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michelle Schmiegelow's work include Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Michelle Schmiegelow is often cited by papers focused on Cardiovascular Function and Risk Factors (6 papers), Heart Failure Treatment and Management (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Michelle Schmiegelow collaborates with scholars based in Denmark and United States. Michelle Schmiegelow's co-authors include Christian Torp‐Pedersen, Gunnar Gislason, Charlotte Andersson, Jonas Bjerring Olesen, Lars Køber, Christine Benn Christiansen, Peter Riis Hansen, Peter Weeke, Mark A. Hlatky and Thomas Bo Jensen and has published in prestigious journals such as JAMA, Circulation and Annals of Internal Medicine.

In The Last Decade

Michelle Schmiegelow

33 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle Schmiegelow Denmark	17	391	158	136	95	89	34	810
Audra Boscoe United States	14	154 0.4×	213 1.3×	95 0.7×	122 1.3×	197 2.2×	29	955
Allison Freeman United States	8	131 0.3×	123 0.8×	165 1.2×	84 0.9×	36 0.4×	9	905
Huei‐Kai Huang Taiwan	18	143 0.4×	167 1.1×	114 0.8×	170 1.8×	64 0.7×	67	892
Timur Meşe Türkiye	14	256 0.7×	209 1.3×	60 0.4×	162 1.7×	26 0.3×	111	682
Gönenç Kocabay Türkiye	16	729 1.9×	155 1.0×	83 0.6×	219 2.3×	50 0.6×	70	1.1k
Toshiki Maeda Japan	16	140 0.4×	161 1.0×	107 0.8×	182 1.9×	50 0.6×	89	653
Suresh Chandran United Kingdom	12	140 0.4×	151 1.0×	247 1.8×	82 0.9×	31 0.3×	62	676
Maria Kohl Austria	17	118 0.3×	84 0.5×	72 0.5×	135 1.4×	78 0.9×	30	709
Ewa Król Poland	15	175 0.4×	92 0.6×	75 0.6×	55 0.6×	16 0.2×	61	587
Yuko Nakagawa Japan	13	182 0.5×	180 1.1×	68 0.5×	138 1.5×	60 0.7×	51	734

Countries citing papers authored by Michelle Schmiegelow

Since Specialization

Citations

This map shows the geographic impact of Michelle Schmiegelow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Schmiegelow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Schmiegelow more than expected).

Fields of papers citing papers by Michelle Schmiegelow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Schmiegelow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Schmiegelow. The network helps show where Michelle Schmiegelow may publish in the future.

Co-authorship network of co-authors of Michelle Schmiegelow

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Schmiegelow. A scholar is included among the top collaborators of Michelle Schmiegelow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Schmiegelow. Michelle Schmiegelow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petersen, Jeppe Kofoed, Michelle Schmiegelow, Eva Havers‐Borgersen, et al.. (2024). Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study. International Journal of Cardiology. 418. 132608–132608.

Schmiegelow, Michelle, Hanne Elming, Kirstine Lærum Sibilitz, et al.. (2021). Reintervention rates following bioprosthetic surgical aortic valve replacement—a Danish Nationwide Cohort Study. European Journal of Cardio-Thoracic Surgery. 61(3). 614–622. 2 indexed citations

Schmiegelow, Michelle, Thomas Alexander Gerds, Morten Schou, et al.. (2021). Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low‐Risk Population With Type 2 Diabetes Mellitus. Journal of the American Heart Association. 10(13). e020395–e020395. 12 indexed citations

Schmiegelow, Michelle, Caroline Holm Nørgaard, Thomas Alexander Gerds, et al.. (2019). Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?. European Heart Journal. 41(13). 1346–1353. 49 indexed citations

Schmiegelow, Michelle, Lars Idorn, Gunnar Gislason, et al.. (2019). Cardiovascular complications in patients with total cavopulmonary connection: A nationwide cohort study. International Journal of Cardiology. 305. 120–126. 4 indexed citations

Christiansen, Christine Benn, et al.. (2018). Incidence of new onset cancer in patients with a myocardial infarction – a nationwide cohort study. BMC Cardiovascular Disorders. 18(1). 198–198. 49 indexed citations

Oestergaard, L, Michelle Schmiegelow, Niels Eske Bruun, et al.. (2018). Staphylococcus aureus Bacteremia in Children Aged 5-18 Years—Risk Factors in the New Millennium. The Journal of Pediatrics. 203. 108–115.e3. 13 indexed citations

Oestergaard, L, Michelle Schmiegelow, Niels Eske Bruun, et al.. (2017). The associations between socioeconomic status and risk of Staphylococcus aureus bacteremia and subsequent endocarditis – a Danish nationwide cohort study. BMC Infectious Diseases. 17(1). 589–589. 29 indexed citations

Gislason, Gunnar, Lynn L. Moore, Charlotte Andersson, et al.. (2016). Associations between metabolic disorders and risk of cancer in Danish men and women – a nationwide cohort study. BMC Cancer. 16(1). 133–133. 15 indexed citations

10.

Schou, Morten, Michelle Schmiegelow, Christian Torp‐Pedersen, et al.. (2016). Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study. International Journal of Cardiology. 221. 944–950. 15 indexed citations

11.

Schmiegelow, Michelle, et al.. (2015). Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter-Defibrillator Among Patients With Mild Heart Failure. Annals of Internal Medicine. 163(6). 417–426. 18 indexed citations

12.

Schou, Morten, Michelle Schmiegelow, Christian Torp‐Pedersen, et al.. (2015). Use of digoxin is safe in patients with atrial fibrillation and heart failure:A nationwide propensity matched study. VBN Forskningsportal (Aalborg Universitet). 2 indexed citations

13.

Schmiegelow, Michelle, Charlotte Andersson, Lars Køber, et al.. (2014). Associations Between Body Mass Index and Development of Metabolic Disorders in Fertile Women—A Nationwide Cohort Study. Journal of the American Heart Association. 3(2). e000672–e000672. 17 indexed citations

14.

Schmiegelow, Michelle, Christian Torp‐Pedersen, Gunnar Gislason, et al.. (2012). Relation of Body Mass Index to Risk of Stent Thrombosis After Percutaneous Coronary Intervention. The American Journal of Cardiology. 110(11). 1592–1597. 8 indexed citations

15.

Andersson, Charlotte, Allan Vaag, Christian Selmer, et al.. (2012). Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3.6 million people. BMJ Open. 2(3). e000433–e000433. 34 indexed citations

16.

Schmiegelow, Michelle, Ole Dyg Pedersen, Lars Køber, et al.. (2011). Incidence of Atrial Fibrillation in Patients with either Heart Failure or Acute Myocardial Infarction and Left Ventricular Dysfunction: A Cohort Study. BMC Cardiovascular Disorders. 11(1). 19–19. 10 indexed citations

17.

Andersson, Charlotte, Gunnar Gislason, Casper H. Jørgensen, et al.. (2011). Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure. Diabetes Research and Clinical Practice. 94(1). 119–125. 19 indexed citations

18.

Andersson, Charlotte, Peter Riis Hansen, Emil Loldrup Fosbøl, et al.. (2010). Heart Failure Severity, as Determined by Loop Diuretic Dosages, Predicts the Risk of Developing Diabetes After Myocardial Infarction: A Nationwide Cohort Study. European Journal of Heart Failure. 12(12). 1333–1338. 61 indexed citations

19.

Olesen, Jonas Bjerring, Peter Riis Hansen, Steen Z. Abildstrøm, et al.. (2010). VALPROATE ATTENUATES THE RISK OF MYOCARDIAL INFARCTION IN PATIENTS WITH EPILEPSY: A NATIONWIDE COHORT STUDY. Journal of the American College of Cardiology. 55(10). A54.E516–A54.E516. 4 indexed citations

20.

Olesen, Jonas Bjerring, Peter Riis Hansen, Steen Z. Abildstrøm, et al.. (2010). Valproate attenuates the risk of myocardial infarction in patients with epilepsy: a nationwide cohort study. Pharmacoepidemiology and Drug Safety. 20(2). 146–153. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact